Shimadzu Medical Systems team up with Change Healthcare Cardiology

SAN DIEGO, Sept. 25, 2018 — Shimadzu Medical Systems USA and Change Healthcare, have entered a partnership through which Shimadzu will offer Change Healthcare Cardiology™ Hemo, along with its Trinias line of angiography systems. The announcement was made today at the annual Transcatheter Cardiovascular Therapeutics (TCT2018) meeting in San Diego.

More than 130 million adults in the U.S. are projected to have some form of cardiovascular disease (CVD) by 2035. The costs associated with caring for CVD are unsustainable, and reimbursement models are shifting. To support providers looking to grow their cardiovascular service line and implement technology while maintaining financial responsibility, augmenting the Trinias line is part of a complete interventional lab package.

"We are proud to solidify a partnership with Change Healthcare, and extend the capabilities of their cardiology hemodynamics solution to achieve a shared initiative of providing healthcare organizations with solutions that hel p them meet their operational and quality initiatives," said Tim Stevener, Director of Cardiology NA for Shimadzu Medical Systems. "Our companies are well aligned to provide an unmatched cardiology offering. With this collaboration, we look forward to a promising relationship with Change Healthcare."

"This partnership shows our commitment to continue to work with other industry leaders to provide options for customers that will help them grow their business while providing quality care to the populations they serve," said Aaron Green, SVP and GM, Cardiology, Change Healthcare. "The combination of the Trinias system and Change Healthcare Cardiology Hemo provides a unique offering for organizations looking for a complete solution with mutually exclusive benefits to meet the high demands of a hybrid interventional lab."

Trinias is a unique single plane system available in floor or ceiling mounts or as a Bi-plane mounted system, offering unmatched design movements around the patient. Change Healthcare Hemo is the integrated hemodynamic monitoring system for cardiology departments that need to aggregate hemodynamic data, waveforms, and images in one cardiac patient record. The combined offering is now available through Shimadzu and its reseller network.

For more information on Shimadzu Medical Systems, please visit our website. Follow us on Twitter, Like us on Facebook, Connect with us on LinkedIn and see us on YouTube

About Shimadzu
Shimadzu Corporation, founded in 1875 in Kyoto, Japan and the parent of Shimadzu Medical Systems USA (SMS), is a global provider of medical diagnostic equipment including conventional, interventional and digital X-Ray systems. Shimadzu Medical Systems USA is headquartered in Torrance California with Sales and Service offices throughout the United States, the Caribbean and Canada with Direct Operations headquartered out of Cleveland, OH; Dallas,TX; and the  greater Chicago area. Visit SMS at:  www.shimadzu-usa.com or call (800) 228-1429.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.